Abiopharma

Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast

(99% Neutral) ETHZilla Corporation (ATNFW) Announces Business Combination

(97% Neutral) BioNexus Gene Lab Corp. (BGLC) Announces Business Combination

Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10th ESWI Influenza Conference 2025

(99% Neutral) RAPT Therapeutics, Inc. (RAPT) Announces Business Combination

(90% Positive) MOLECULIN BIOTECH, INC. (MBRX) Provides Update on based for pancreatic cancer HOUSTON

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-Hs EMBODY Program

Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

Pacira BioSciences to Present New Data from Three Real-World Studies with EXPAREL®

LifeMD to Report Third Quarter 2025 Financial Results on November 6

Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10ᵗʰ ESWI Influenza Conference 2025

Gilead to Showcase Interim Long-Term Efficacy Data for Livdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta

Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting